Xtx Topco LTD Unicycive Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Unicycive Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 171,463 shares of UNCY stock, worth $109,736. This represents 0.01% of its overall portfolio holdings.
Number of Shares
171,463
Previous 70,784
142.23%
Holding current value
$109,736
Previous $29,000
365.52%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding UNCY
# of Institutions
31Shares Held
61.7MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT11MShares$7.03 Million5.72% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT10.4MShares$6.65 Million0.41% of portfolio
-
Octagon Capital Advisors LP New York, NY10MShares$6.4 Million1.76% of portfolio
-
Vivo Capital, LLC Palo Alto, CA9.97MShares$6.38 Million1.54% of portfolio
-
Logos Global Management LP San Francisco, CA5.08MShares$3.25 Million0.53% of portfolio
About Unicycive Therapeutics, Inc.
- Ticker UNCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,052,500
- Market Cap $9.63M
- Description
- Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...